INNOVATE swings to a Q2 profit as revenues surge 74.2% y/y, fueled by DBM Global's growth, wider margins and backlog gains, while debt and liquidity remain in focus.
INNOVATE NYSE: VATE reported second-quarter 2026 revenue of $421.6 million, up 74.2% from $242 million a year earlier, as its Infrastructure segment delivered record revenue, wider margins and backlog growth. The company posted net income attributable to common and participating preferred stockholders of $10.4 million, or $0.71 per fully diluted share, compared with a net loss of $22 million, or $1.67 per fully diluted share, in the prior-year quarter.
INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 75 | $1,400.25 | $463.12 | -$937.13 | -66.93% |
| CD Charlie Durham Sterling Capital Management LLC | 30 | $560 | $179.1 | -$380.9 | -68.02% |
Hui Fai Tam Caitong International Asset Management Co. Ltd. | 29 | $164.65 | $180.09 | $15.44 | 9.38% |
Christopher C. Powers Farther Finance Advisors, LLC | 326 | $2,422 | $2,014.68 | -$407.32 | -16.82% |
Mark Schafer Police & Firemen's Retirement System of New Jersey | 2,380 | $44,435 | $14,208.6 | -$30,226.4 | -68.02% |
| Construction & Engineering Industry | Industrials Sector | Paul Kenneth Voigt CEO | NYSE Exchange | 45784J303 CUSIP |
| US Country | 3,663 Employees | 13 Apr 2026 Last Dividend | 9 Aug 2024 Last Split | - IPO Date |
INNOVATE Corp., operating through its subsidiaries in the United States, is a diversified conglomerate with a focus on infrastructure, life sciences, and spectrum industries. The company, previously known as HC2 Holdings, Inc., rebranded to INNOVATE Corp. in September 2021. Since its inception in 1994, and being headquartered in New York, New York, INNOVATE has expanded its services and product offerings to cater to a wide range of sectors including commercial, industrial, and infrastructure projects, as well as in the development of medical and aesthetic technologies.